标题
Pharmacological chaperones for human -N-acetylgalactosaminidase
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 43, Pages 17400-17405
出版商
Proceedings of the National Academy of Sciences
发表日期
2012-10-09
DOI
10.1073/pnas.1203924109
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Scalable Syntheses of Both Enantiomers of DNJNAc and DGJNAc from Glucuronolactone: The Effect of N-Alkylation on Hexosaminidase Inhibition
- (2012) Andreas F. G. Glawar et al. CHEMISTRY-A EUROPEAN JOURNAL
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase
- (2011) Abigail I. Guce et al. CHEMISTRY & BIOLOGY
- Pharmacological chaperone therapy for Gaucher disease: a patent review
- (2011) Juan M Benito et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Crystal Structure of Human β-Galactosidase
- (2011) Umeharu Ohto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases
- (2010) Ivan B. Tomasic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells
- (2010) Kalvin J. Gregory et al. PLoS One
- Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases
- (2010) Daniel Best et al. TETRAHEDRON LETTERS
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability
- (2009) Raquel L. Lieberman et al. BIOCHEMISTRY
- Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity
- (2009) Marilena Greco et al. CANCER LETTERS
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Catalytic Mechanism of Human α-Galactosidase
- (2009) Abigail I. Guce et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pharmacological chaperone 1-deoxygalactonojirimycin increases α-galactosidase A levels in Fabry patient cell lines
- (2009) E. R. Benjamin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The 1.9 Å Structure of Human α-N-Acetylgalactosaminidase: The Molecular Basis of Schindler and Kanzaki Diseases
- (2009) Nathaniel E. Clark et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular interaction of imino sugars with human α-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease
- (2009) Kanako Sugawara et al. MOLECULAR GENETICS AND METABOLISM
- Glycosylation status of vitamin D binding protein in cancer patients
- (2009) Douglas S. Rehder et al. PROTEIN SCIENCE
- Substrate reduction therapy
- (2008) Frances M Platt et al. ACTA PAEDIATRICA
- The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics
- (2008) B. L. Cantarel et al. NUCLEIC ACIDS RESEARCH
- A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
- (2007) Jian-Qiang Fan BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started